Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
Clinical trial NCT00118274 · COMPLETED
Trial details
- NCT number
- NCT00118274
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2010-02-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.